PNOĒ 2.0: Self‑Serve Breath‑Based Metabolic Testing Set to Launch Oct 1
PNOĒ, a Massachusetts‑based startup with offices in Athens, Greece, announced that its next‑generation metabolic testing mask, the PNOĒ 2.0, will become available on October 1. The new device allows users to perform a full VO₂ max and metabolic profile assessment on their own, a shift from the company’s current operator‑required model.
Key Takeaways
- PNOĒ 2.0 launches Oct 1, enabling self‑administered breath tests.
- The mask measures VO₂ max, resting metabolic rate, metabolic flexibility, and 23 additional biomarkers.
- Clients include Equinox, Four Seasons, Red Bull, the NBA, Mount Sinai, and Restore Hyper Wellness.
- Subscription fees range from $400 to over $1,000 per month, covering hardware, software, and marketing.
- The company has raised $22 million, with a recent $11 million round led by 50 Years and Lars Rasmussen.
| Metric | Value | Why it matters |
|---|---|---|
| Launch date | October 1 | Marks the first commercial release of a self‑serve metabolic mask. |
| CEO | Apostolos Atsalakis | Provides strategic direction and public commentary. |
| Funding total | $22 million | Supports product development and market expansion. |
| Subscription range | $400–$1,000/month | Represents the cost model for business partners. |
What is PNOĒ 2.0?
The PNOĒ 2.0 is a compact mask that covers the nose and mouth and is secured with a rear head strap. Unlike its predecessor, the new version is designed for self‑administration: a user can wear the mask, press a button, and breathe for eight minutes without a trained operator. The device’s electronics detach from the silicone mask, allowing multiple users to share the hardware while each keeps a personal mask.
How the Device Works
PNOĒ’s technology analyzes the composition of exhaled gases to determine VO₂ max, resting metabolic rate, and metabolic flexibility. In addition to these core metrics, the mask captures 23 biomarkers that provide insight into how the body switches between fat and carbohydrate oxidation. The software translates raw gas data into actionable recommendations for diet, training, and lifestyle, positioning the device as a wellness tool rather than a medical diagnostic.
Business Model and Partnerships
PNOĒ sells the system exclusively to businesses, which then offer the test to their clientele. The “business in a box” subscription includes hardware, software, training, and marketing collateral. Current partners span the fitness, hospitality, and health sectors: Equinox clubs, Four Seasons hotels, Red Bull, the NBA, Mount Sinai Health System, and the med‑spa chain Restore Hyper Wellness. Approximately 85 % of revenue originates from the United States, the company’s largest market for longevity services.
Scientific Foundations and Accuracy
Metabolic testing has been the gold standard for measuring VO₂ max for over a century. Traditional protocols require bulky, expensive equipment found mainly in sports laboratories and hospitals, limiting accessibility to elite athletes and corporate wellness programs. PNOĒ claims its portable mask delivers comparable accuracy, making comprehensive metabolic profiling available to a broader audience. The company’s founder, Apostolos Atsalakis, traces the idea back to his PhD work in sensing technologies at the University of Cambridge.
Regulatory Status and Future Potential
PNOĒ is not FDA‑cleared and does not provide medical recommendations. The device is marketed as a wellness instrument, comparable to a body‑composition scale. Atsalakis notes that while the mask can detect biomarkers linked to disease, full diagnostic capabilities are likely several years away due to regulatory hurdles. The company is exploring whether breath analysis could eventually flag conditions such as cancer.
Market Landscape and Competition
The self‑serve metabolic testing niche is increasingly crowded. Consumer wearables from Apple, Garmin, and Whoop estimate VO₂ max using heart‑rate data, while breath‑based devices like Lumen assess fat and carbohydrate oxidation. PNOĒ’s approach distinguishes itself by offering a clinically validated VO₂ max measurement in a portable, user‑friendly format.
Why it matters
As longevity research links higher cardiorespiratory fitness to lower mortality, accurate VO₂ max data is becoming a key metric for wellness programs. PNOĒ’s self‑serve model could democratize access to this data, allowing fitness centers, hotels, and health systems to provide personalized recommendations without hiring specialized staff. The company’s growing data set also positions it to explore future diagnostic applications, potentially expanding its role in preventive health.
Frequently Asked Questions
What does the PNOĒ 2.0 mask measure?
The mask captures VO₂ max, resting metabolic rate, metabolic flexibility, and 23 additional biomarkers derived from exhaled gases.
How is the device used in a typical setting?
A user wears the mask, presses a start button, and breathes for eight minutes. The device records gas composition and processes the data into actionable insights via the accompanying software.
Is the PNOĒ 2.0 FDA‑cleared?
No. The company states it is a wellness device and does not provide medical recommendations.
Who can purchase the PNOĒ system?
Only businesses may buy the system; individual consumers must access the service through a partner such as a gym or spa.
What are the subscription costs for partners?
Subscriptions range from $400 to over $1,000 per month, covering hardware, software, training, and marketing materials.
Bottom Line
PNOĒ’s upcoming self‑serve mask represents a notable step toward making clinically accurate metabolic testing accessible outside specialized labs. By combining a portable device with a subscription‑based service model, the company positions itself at the intersection of fitness, hospitality, and health sectors. While regulatory constraints limit its current medical claims, the technology’s potential to inform personalized wellness strategies—and possibly future diagnostics—makes it a compelling development in the longevity and wellness landscape.
Reporting based on: original source.
Comments
Post a Comment